Lv12
80 积分 2023-03-14 加入
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
4小时前
已关闭
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non–Small Cell Lung Carcinoma with Poor Prognosis
1个月前
已完结
MET alterations in advanced non-small cell lung cancer
1个月前
已完结
Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?
1个月前
已完结
Response to hepatic arterial infusion chemotherapy combined with camrelizumab and targeted therapy in advanced primary hepatic neuroendocrine carcinoma: a case report and literature review
1个月前
已完结
Recent Clinical Advances in Rare Gastrointestinal Tumors
8个月前
已完结
Advancing therapy for osteosarcoma
8个月前
已完结
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors
8个月前
已关闭
SWI/SNF chromatin remodeling complex alterations in meningioma
9个月前
已完结
皖公网安备34019202002308
